12-114399544-C-A

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 3P and 20B. PM1PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_181486.4(TBX5):​c.331G>T​(p.Asp111Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00418 in 1,614,124 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 14 hom. )

Consequence

TBX5
NM_181486.4 missense

Scores

9
8
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 6.17
Variant links:
Genes affected
TBX5 (HGNC:11604): (T-box transcription factor 5) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

PM1
In a DNA_binding_region T-box (size 180) in uniprot entity TBX5_HUMAN there are 9 pathogenic changes around while only 1 benign (90%) in NM_181486.4
PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, Eigen, PrimateAI, PROVEAN, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.061571628).
BP6
Variant 12-114399544-C-A is Benign according to our data. Variant chr12-114399544-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 213813.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-114399544-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0038 (578/152240) while in subpopulation AMR AF= 0.0107 (163/15284). AF 95% confidence interval is 0.00933. There are 1 homozygotes in gnomad4. There are 275 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 578 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBX5NM_181486.4 linkuse as main transcriptc.331G>T p.Asp111Tyr missense_variant 4/9 ENST00000405440.7 NP_852259.1
TBX5NM_000192.3 linkuse as main transcriptc.331G>T p.Asp111Tyr missense_variant 4/9 NP_000183.2
TBX5NM_080717.4 linkuse as main transcriptc.181G>T p.Asp61Tyr missense_variant 3/8 NP_542448.1
TBX5XM_017019912.2 linkuse as main transcriptc.379G>T p.Asp127Tyr missense_variant 4/9 XP_016875401.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBX5ENST00000405440.7 linkuse as main transcriptc.331G>T p.Asp111Tyr missense_variant 4/91 NM_181486.4 ENSP00000384152 P1Q99593-1

Frequencies

GnomAD3 genomes
AF:
0.00381
AC:
579
AN:
152122
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00879
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00525
Gnomad OTH
AF:
0.00765
GnomAD3 exomes
AF:
0.00334
AC:
840
AN:
251494
Hom.:
4
AF XY:
0.00325
AC XY:
442
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.000984
Gnomad AMR exome
AF:
0.00645
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.000785
Gnomad NFE exome
AF:
0.00477
Gnomad OTH exome
AF:
0.00521
GnomAD4 exome
AF:
0.00422
AC:
6173
AN:
1461884
Hom.:
14
Cov.:
33
AF XY:
0.00411
AC XY:
2987
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.000806
Gnomad4 AMR exome
AF:
0.00682
Gnomad4 ASJ exome
AF:
0.000191
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000278
Gnomad4 FIN exome
AF:
0.00107
Gnomad4 NFE exome
AF:
0.00492
Gnomad4 OTH exome
AF:
0.00454
GnomAD4 genome
AF:
0.00380
AC:
578
AN:
152240
Hom.:
1
Cov.:
32
AF XY:
0.00369
AC XY:
275
AN XY:
74430
show subpopulations
Gnomad4 AFR
AF:
0.000674
Gnomad4 AMR
AF:
0.0107
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.000472
Gnomad4 NFE
AF:
0.00523
Gnomad4 OTH
AF:
0.00757
Alfa
AF:
0.00458
Hom.:
5
Bravo
AF:
0.00441
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.00340
AC:
413
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00518
EpiControl
AF:
0.00539

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 16, 2017- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2022TBX5: PP3, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 05, 2019This variant is associated with the following publications: (PMID: 22011241, 16376438, 19429598, 28251916, 28074886, 30639323) -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Holt-Oram syndrome Benign:3
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 29, 2022- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 01, 2016- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
TBX5-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 16, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Aortic valve disease 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 27, 2024- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 08, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.41
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.92
.;D;D;.
Eigen
Pathogenic
0.81
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.97
D;.;D;D
M_CAP
Uncertain
0.22
D
MetaRNN
Benign
0.062
T;T;T;T
MetaSVM
Uncertain
0.79
D
MutationAssessor
Uncertain
2.9
.;M;M;M
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-7.7
D;D;D;D
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Uncertain
0.0040
D;D;D;D
Polyphen
1.0
.;D;D;D
Vest4
0.94
MVP
0.97
MPC
2.0
ClinPred
0.053
T
GERP RS
4.7
Varity_R
0.91
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77357563; hg19: chr12-114837349; API